Erratum to “Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression”

Lotte B Nielsen,Henrik B Mortensen,Chen-Yu Zhang,Lars Hansen,Kaspar Sørensen,Flemming Pociot,Anders Juul,Marie-Louise M Andersen,Claus H Bang-Berthelsen,Cheng Wang,Philip Hougaard

doi:10.1155/2012/672865

Abstract

Erratum to “Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression”

Highlights

Erratum Erratum to “Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression”
The following sentence: miR-25 one month after diagnosis was positively associated with residual betacell function (P = 0.0037), and negatively associated with glycaemic control (HbA1c) (P = 0.0035) 3 months after disease onset, should replace this sentence in the abstract of the existing paper: we identified miR-25 as negatively associated with residual beta-cell function, and positively associated with glycaemic control (HbA1c) 3 months after onset

Summary

Introduction

Erratum Erratum to “Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression”

Results

Conclusion